Melissa Conrad Stöppler, MD
Melissa Conrad Stöppler, MD, is a U.S. board-certified Anatomic Pathologist with subspecialty training in the fields of Experimental and Molecular Pathology. Dr. Stöppler's educational background includes a BA with Highest Distinction from the University of Virginia and an MD from the University of North Carolina. She completed residency training in Anatomic Pathology at Georgetown University followed by subspecialty fellowship training in molecular diagnostics and experimental pathology.
William C. Shiel Jr., MD, FACP, FACR
Dr. Shiel received a Bachelor of Science degree with honors from the University of Notre Dame. There he was involved in research in radiation biology and received the Huisking Scholarship. After graduating from St. Louis University School of Medicine, he completed his Internal Medicine residency and Rheumatology fellowship at the University of California, Irvine. He is board-certified in Internal Medicine and Rheumatology.
- Amniocentesis may be performed for chromosome analysis or the detection of genetic defects and conditions in the fetus.
- Pregnant women over the age of 35 years are candidates for amniocentesis to detect chromosomal abnormalities in the fetus.
- Amniocentesis can also be used to determine the maturity of the lungs of the fetus or the cause of unknown fever in the mother.
- For genetic testing, chromosome analysis, and the evaluation of an abnormal alpha feto-protein test, amniocentesis is usually performed between the 16th and 21st weeks of pregnancy.
- The risk of fetal loss from the amniocentesis procedure is less than 1%.
What is amniocentesis?
Amniocentesis is a procedure whereby a sample of fluid is removed from the amniotic sac for analysis. The amniotic sac is in the uterine cavity. The amniotic sac is the fluid-filled structure inside a pregnant woman's uterus within which the baby lives. Fetal cells, proteins, and fetal urine freely move within this sac.
During amniocentesis, fluid is removed by placing a long needle through the abdominal wall into amniotic sac. Sometimes, the woman's skin is injected first with a local anesthetic, but this is not usually necessary. The amniocentesis needle is typically guided into the sac with the help of ultrasound imaging performed either prior to or during the procedure. Once the needle is in the sac, a syringe is used to withdraw the clear amber-colored amniotic fluid, that resembles urine. The volume of fluid withdrawn depends upon the age of the fetus and the reason for the testing.
The fluid can then be sent for evaluation of fetal lung maturity, genetic evaluation, evidence of spina bifida (a birth defect in spinal cord development) or other neural-tube defects, the presence of infection, or fetal chromosome analysis. Chromosomes are structures that contain all of the genetic information in our cells. The amniotic fluid contains numerous free-floating fetal cells that can be grown in the laboratory. When these cells multiply and reach a certain number, their chromosomes are extracted and analyzed. It takes about two weeks to perform chromosome analysis. The fluid also contains proteins, minerals and other compounds that can be tested, and these studies may take 1 to 7 days to perform. Data obtained from amniotic fluid can help women make informed decisions regarding their pregnancies.
For most patients, amniocentesis is a fairly quick and comfortable procedure. Some women experience uterine cramping after the procedure. They may also feel faint during or after the test.
Parenting and Pregnancy
Get tips for baby and you.